AS Latvijas Juras medicinas centrs (MU:UOM) — Market Cap & Net Worth
Market Cap & Net Worth: AS Latvijas Juras medicinas centrs (UOM)
AS Latvijas Juras medicinas centrs (MU:UOM) has a market capitalization of $5.92 Million (€5.06 Million) as of June 19, 2026. Listed on the MU stock exchange, this Germany-based company holds position #28254 globally and #2450 in its home market, demonstrating a -8.07% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AS Latvijas Juras medicinas centrs's stock price €7.40 by its total outstanding shares 800000 (800.00K). Review AS Latvijas Juras medicinas centrs debt and liabilities to assess the company's total debt and financial obligations.
AS Latvijas Juras medicinas centrs Market Cap History: 2015 to 2026
AS Latvijas Juras medicinas centrs's market capitalization history from 2015 to 2026. Data shows growth from $2.54 Million to $6.92 Million (12.62% CAGR).
AS Latvijas Juras medicinas centrs Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AS Latvijas Juras medicinas centrs's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.81x
AS Latvijas Juras medicinas centrs's market cap is 0.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
34.54x
AS Latvijas Juras medicinas centrs's market cap is 34.54 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.63 Million | $6.04 Million | -$98.23K | 0.27x | N/A |
| 2017 | $3.05 Million | $6.33 Million | $223.95K | 0.48x | 13.64x |
| 2018 | $4.10 Million | $6.67 Million | $34.62K | 0.61x | 118.37x |
| 2019 | $4.17 Million | $7.27 Million | $164.16K | 0.57x | 25.38x |
| 2020 | $6.76 Million | $7.08 Million | $273.56K | 0.95x | 24.71x |
| 2021 | $11.59 Million | $9.36 Million | $880.26K | 1.24x | 13.16x |
| 2022 | $11.02 Million | $9.70 Million | $625.73K | 1.14x | 17.62x |
| 2023 | $9.91 Million | $9.85 Million | -$624.25K | 1.01x | N/A |
| 2024 | $6.36 Million | $10.19 Million | $185.16K | 0.62x | 34.35x |
| 2025 | $8.32 Million | $10.29 Million | $241.00K | 0.81x | 34.54x |
Competitor Companies of UOM by Market Capitalization
Companies near AS Latvijas Juras medicinas centrs in the global market cap rankings as of June 19, 2026.
Key companies related to AS Latvijas Juras medicinas centrs by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #319 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #999 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1038 globally with a market cap of $25.88 Billion USD ( €22.14 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1336 globally with a market cap of $19.46 Billion USD ( RM77.49 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #319 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $375.17 |
| #999 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1038 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.88 Billion | €39.31 |
| #1336 | IHH Healthcare Bhd | KLSE:5225 | $19.46 Billion | RM8.77 |
AS Latvijas Juras medicinas centrs Historical Marketcap From 2015 to 2026
Between 2015 and today, AS Latvijas Juras medicinas centrs's market cap moved from $2.54 Million to $ 6.92 Million, with a yearly change of 12.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €6.92 Million | -16.85% |
| 2025 | €8.32 Million | +30.88% |
| 2024 | €6.36 Million | -35.85% |
| 2023 | €9.91 Million | -10.08% |
| 2022 | €11.02 Million | -4.85% |
| 2021 | €11.59 Million | +71.41% |
| 2020 | €6.76 Million | +62.26% |
| 2019 | €4.17 Million | +1.65% |
| 2018 | €4.10 Million | +34.17% |
| 2017 | €3.05 Million | +87.61% |
| 2016 | €1.63 Million | -36.03% |
| 2015 | €2.54 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of AS Latvijas Juras medicinas centrs was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.92 Million USD |
| MoneyControl | $5.92 Million USD |
| MarketWatch | $5.92 Million USD |
| marketcap.company | $5.92 Million USD |
| Reuters | $5.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About AS Latvijas Juras medicinas centrs
AS Latvijas Juras medicinas centrs provides health care services in the Republic of Latvia. The company engages in the general and special medical practice, dental practice, human health, residential nursing care, residential care, social work, physical well-being, and other personal service activities. It also involved in provision of other education services related activities. In addition, the… Read more